CureMatch, Inc., a healthcare technology company that leverages artificial intelligence (AI) to power precision medicine support for oncology, announced today that David Szekeres has been named board director. Mr. Szekeres is a seasoned executive with over 20 years in the life sciences industry, with deep operational, commercial, corporate development, strategy, financial, investor relations, and legal […]
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.